Jaykaran Charan
Impact in
-
- Antibiotic Use and Resistance
- Infectious Diseases top 2%
- SARS-CoV-2 and COVID-19 Research
- COVID-19 Clinical Research Studies
Papers in
-
- COVID-19 Clinical Research Studies 13
- SARS-CoV-2 and COVID-19 Research 8
-
- Pharmaceutical Economics and Policy 5
- Co-authors
- Tamoghna Biswas (1 shared paper)N. D. Kantharia (2 shared papers)Rimple Jeet Kaur (18 shared papers)Deepak Saxena (17 shared papers)Pankaj Bhardwaj (26 shared papers)Jagdish Prasad Goyal (12 shared papers)Siddhartha Dutta (24 shared papers)Mainul Haque (21 shared papers)
- Journals
- Expert Review of Anti-infective Therapy (3 papers)Infection and Drug Resistance (3 papers)Expert Opinion on Drug Safety (2 papers)PLoS ONE (2 papers)Expert Review of Neurotherapeutics (1 paper)
- Partner nations
- IndiaMalaysiaBangladesh
In The Last Decade
Jaykaran Charan
90 papers receiving 5.2k citations
Jaykaran Charan's Hit Papers
Peers
Comparison fields: 5 of 186
- Applied Microbiology and Biotechnology 145
- Infectious Diseases 668
- Geriatrics and Gerontology 79
- Nutrition and Dietetics 314
- Health 158
Countries citing papers authored by Jaykaran Charan
This map shows the geographic impact of Jaykaran Charan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jaykaran Charan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jaykaran Charan more than expected).
Fields of papers citing papers by Jaykaran Charan
This network shows the impact of papers produced by Jaykaran Charan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jaykaran Charan. The network helps show where Jaykaran Charan may publish in the future.
Co-authors
The 25 scholars most cited alongside Jaykaran Charan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 99 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | How to Calculate Sample Size for Different Study Designs in Medical Research? Hit paper breakdown → | 2013 | 2108 |
| 2 | How to calculate sample size in animal studies? Hit paper breakdown → | 2013 | 1374 |
| 3 | Monoclonal Antibodies: A Review Hit paper breakdown → | 2017 | 272 |
| 4 | 2021 | 183 | |
| 5 | 2012 | 161 | |
| 6 | 2020 | 126 | |
| 7 | 2021 | 98 | |
| 8 | 2021 | 73 | |
| 9 | 2021 | 54 | |
| 10 | 2020 | 53 | |
| 11 | 2020 | 52 | |
| 12 | 2020 | 50 | |
| 13 | 2022 | 43 | |
| 14 | 2011 | 42 | |
| 15 | 2021 | 38 | |
| 16 | 2021 | 36 | |
| 17 | Antibiotics for the treatment of leptospirosis: systematic review and meta-analysis of controlled trials. | 2013 | 35 |
| 18 | 2016 | 32 | |
| 19 | 2020 | 30 | |
| 20 | 2016 | 30 |
About Jaykaran Charan
Jaykaran Charan is a scholar working on Infectious Diseases, Economics and Econometrics, Surgery, Public Health, Environmental and Occupational Health and Statistics, Probability and Uncertainty, having authored 99 papers that have together received 5.4k indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (13 papers), SARS-CoV-2 and COVID-19 Research (8 papers), Meta-analysis and systematic reviews (6 papers), Antibiotic Use and Resistance (6 papers), Pharmaceutical Economics and Policy (5 papers), Antibiotic Resistance in Bacteria (5 papers), Vitamin D Research Studies (4 papers) and COVID-19 epidemiological studies (3 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (145 citations), Infectious Diseases (668 citations), Geriatrics and Gerontology (79 citations), Nutrition and Dietetics (314 citations) and Health (158 citations). Jaykaran Charan has collaborated with scholars based in India, Malaysia and Bangladesh. Frequent co-authors include Tamoghna Biswas, N. D. Kantharia, Rimple Jeet Kaur, Deepak Saxena, Pankaj Bhardwaj, Jagdish Prasad Goyal, Siddhartha Dutta, Mainul Haque, Preeti Yadav and Surjit Singh. Their work appears in journals such as Expert Review of Anti-infective Therapy, Infection and Drug Resistance, Expert Opinion on Drug Safety, PLoS ONE and Expert Review of Neurotherapeutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.